Macrophages are innate immune cells with well-established roles in the primary response to pathogens, but also in tissue homeostasis, coordination of the adaptive immune response, inflammation, resolution, and repair. These cells recognize danger signals through receptors capable of inducing specialized activation programs. The classically known macrophage activation is induced by IFN-γ, which triggers a harsh proinflammatory response that is required to kill intracellular pathogens. Macrophages also undergo alternative activation by IL-4 and IL-13, which trigger a different phenotype that is important for the immune response to parasites. Here we review the cellular sources of these cytokines, receptor signaling pathways, and induced markers and gene signatures. We draw attention to discrepancies found between mouse and human models of alternative activation. The evidence for in vivo alternative activation of macrophages is also analyzed, with nematode infection as prototypic disease. Finally, we revisit the concept of macrophage activation in the context of the immune response. 
In 1905, he summarized the evidence that phagocytic mononuclear cells from animals resistant to certain bacterial infections were more adept at killing those and unrelated bacteria, setting the basis for the concept of "macrophage activation" (1) . However, 60 more years of combined work were required to define how M s become more efficient bacterial killers. In their work regarding M activity in acquired resistance to intracellular bacteria, Mackaness, North, and their colleagues realized that protection against infection was mediated not only by humoral, but also by independent cellular factors (2, 3) . In this response they defined a form of acquired resistance to intracellular bacteria that could not be passively transferred with serum, yet induced a spectrum of consistent morphologic and functional changes in the antibacterial activity of M s. Importantly, they noted that the antibacterial mechanism was not directed exclusively against the organism that provoked it. Bloom, Bennett, and David were among those who helped to identify lymphocytes as the major antigen-specific cells responsible for M microbicidal activation and consequent transfer of resistance against families of different intracellular pathogens (4, 5) . Soon thereafter, the key factor for collaboration between these cells was discovered: interferon (IFN)-γ (6) . IFN-γ is produced by activated CD4 + T helper 1 cells (Th1), CD8
+ T cytotoxic 1 (Tc1) cells, and natural killer (NK) cells. This cytokine converts resting M s into potent cells with increased antigen presenting capacity, increased synthesis of proinflammatory cytokines and toxic mediators, and augmented complement-mediated phagocytosis. Thus, M s acquire the capacity for killing of bacteria, especially intracellular pathogens, and perhaps tumors. As the first type of antimicrobial M activation to be recognized, it became known as "classical activation of M s."
In 1982, the immunological counterpart of IFN-γ, interleukin (IL)-4, was identified by Howard, Vitetta, Paul, and colleagues (7) . Coffman, Mosmann, and collaborators provided evidence that IFN-γ and IL-4 are produced by mutually inhibitory CD4
+ T helper cells: Th1 and Th2 (8) . In naive T helper cells, IL-4 and IFN-γ genes are silent; upon TCR engagement and costimulation Th cells begin to choose between Th1 and Th2 cell fates. Knowledge of mutual exclusion led to the discovery that Th2 cells also produce IL-10 to suppress Th1 cells (8) . Th2 cells also secrete IL-13, a cytokine that partially shares ligand binding receptor complexes with IL-4 (9) . In contrast to IFN-γ, IL-4 and IL-13 mediate immune responses typically characterized by eosinophilia, basophilia, mastocytosis, enhanced B cell class switching, and antibody production, with consequent plasma accumulation of IgE and IgG1. Th2 responses are essential for the control of extracellular parasites, including helminths, protozoa, and fungi, but also contribute to allergy, increased susceptibility to other pathogens, and complications of infection such as fibrosis ( Table 1) .
Initial observations regarding the role of IL-4 in M activation showed that this cytokine was able to inhibit the respiratory burst and the production of IL-1β and IL-8 (10) . It was also shown that IL-4 induced MHC class II expression, and M -M fusion and that IL-4 came to play an essential role in M -mediated control of the protozoon Trypanosoma cruzi (11) (12) (13) . Importantly, it was found that IL-13 induces both redundant and nonredundant effects to those of IL-4 in M s (9) . With the finding in 1992 of upregulation of mannose receptor (MRC1) as a distinctive marker of IL-4-activated M s, together with the induction of MHC class II antigens, the concept of alternative activation was proposed, stating, "IL-4 in an inflammatory focus would cause recruited macrophages to acquire an entirely different phagocytic receptor and secretory capability compared with macrophages classically activated by IFN-γ treatment or BCG infection" (14) .
In the following years, we learned that the phagocytic and secretory profile of M s could be further modified by many other self and pathogen-derived signals (15) (16) (17) . The main stimuli associated with distinctive M phenotypes include glucocorticoids (GC) recognized by the GCR (glucocorticoid receptor), IL-10 recognized by IL-10R1, and immune complexes recognized by the Fc receptor family, among others. The fact that these phenotypes are all alternatives to classical activation and show a partial overlap with the effects of IL-4 and IL-13 has fuelled confusion in the field over the past decade. Since the discovery of activation and its heterogeneity, several classification schemes have been proposed, the most recent of which defines classically activated M (caM ) as M1, and the group of non-caM as M2a-c (16) . Before discussing the uniqueness of IL-4/IL-13 or IFN-γ activa-tion in relation to other forms of M stimulation, and the classification system in use, we review and clarify current knowledge concerning IL-4-/IL-13-activated M s, based on recent findings regarding cytokine production, signaling, and effects on M s. In addition, we assess primary evidence for alternative activation in vivo, with emphasis on parasitic disorders and allergy, and discuss where we are in the field, critically analyzing the less developed areas.
IL-4 AND IL-13 RECEPTORS AND SIGNALING

IL-4 and IL-13 Receptors and Adaptors
IL-4 is recognized by the membrane receptor IL-4Rα, a unique member of the common gamma chain (γ c ) family of receptors (18) , characterized by conserved structural motifs in the extracellular region (19) . These motifs include STAT6: signal transducers and activators of transcription protein 6 conserved paired cysteine residues and, in the membrane proximal region, a WSXWS motif required for the conformation of the receptor chain, which mediates specific cytokine binding (20) . The IL-4Rα chain binds IL-4 with high affinity (21) , leading to dimerization with another protein to form either type I or type II receptors (Figure 1a) . In most cells of the hemopoietic lineage, the type I receptor arises by recruitment of the γ c chain (22, 23) . In nonhemopoietic and myeloid hemopoietic cells, IL-4Rα can recruit IL-13Rα1 (24), forming the type II receptor. Dimerization leading to the formation of either type I or type II receptors induces a cytoplasmic signaling cascade that involves the Janus kinase family (25) (26) (27) , the insulin receptor substrate family (23) , and the phosphoinositide 3-kinase (PI3K) pathway. Janus kinase activation leads to phosphorylation of STAT6 (signal transducer and activator of transcription 6), which dimerizes, migrates to the nucleus, and binds to promoters of genes (28) (Figure 1b) .
The type II receptor is the main functional receptor for IL-13 (21) . In addition, IL-13 is recognized with high affinity by the IL-13Rα2 receptor (29) , endowed with a very short intracellular domain. Kawakami and colleagues (29) found that IL-13Rα2 undergoes internalization after ligand binding without causing signaling and proposed a role as decoy receptor. Furthermore, while IL-13 efficiently caused activation of STAT6 protein in cells transfected with the IL-13Rα1 and IL-4Rα chains, IL-13Rα2 inhibited this activation (29) . Novel findings challenge the status of the IL-13Rα2 as a decoy receptor in M s (30) . Fichtner-Feigl and colleagues (30) showed that IL-13 and tumor necrosis factor (TNF) cooperate to induce the expression of IL-13Rα2; IL-13 then signals through IL-13Rα2 to activate an AP-1 variant containing c-jun and Fra-2, which activates the promoter of tumor growth factor (TGF)-β, leading to its production. Prevention of IL-13Rα2 expression, gene silencing, or blockade of IL-13Rα2 signaling led to marked downregulation of TGF-β production in oxazolone-induced colitis and bleomycininduced lung fibrosis (30) . These data suggest that IL-13Rα2 signaling may become functional during prolonged inflammation (30) .
Although the signaling of IL-4 and IL-13 has been considered equivalent, there are differences between them in terms of signaling intensity and kinetics. The epithelial carcinoma cell line A549 has been a useful model to study signaling by the common type II receptor, since it expresses IL-4Rα and IL-13Rα1, but not the γ c or the decoy receptor IL-13Rα2 (31) . In this model, IL-4 induced STAT6 phosphorylation at five-to tenfold lower concentrations than IL-13. IL-4 signaling in the human B cell line Ramos, which expresses γ c chain and IL-4Rα, stimulated tyrosine phosphorylation of STAT6 with a dose-response similar to that observed in A549. At all concentrations, IL-4 rapidly induced tyrosine phosphorylation of STAT6 in A549, reaching plateau levels between 10-15 min of stimulation, whereas the response to IL-13 was substantially slower. The relative delay in STAT6 phosphorylation induced by IL-13 via the type II receptor complex was most apparent at lower concentrations of the cytokines (31).
Interaction Between IL-4/IL-13 Pathway and Other Signaling Pathways
The IL-4/IL-13 cascades depend on and contribute to other signaling pathways, reminiscent of the cross talk between Toll-like receptor (TLR) and IFN pathways. However, since these findings are relatively new, the relation between the pathways is not always clear. Emergent examples are represented by interaction with nuclear receptors such as the peroxisome proliferator-activated receptors, PPARδ and PPARγ and the GCR, but also membrane molecules and cytokines such as galectin-3, IL-10, and IL-21, among others.
PPARδ and PPARγ seem to coordinate the M transcriptional response to IL-4 and IL-13 at the gene transcription level (32) (33) (34) . Studies with PPARδ −/− , PPARγ −/− , and PPARδ/γ
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Type II Recognition and signaling machinery of IL-4 and IL-13. (a) Recently, LaPorte and colleagues (31) defined the three-dimensional structures of the type I (IL-4Rα/IL-4/γ c ) and type II (IL-4Rα/IL-4/IL-13Rα1 or IL-13Rα1/IL-13/IL-4Rα) ternary signaling complexes (the order shown in parentheses coincides with the order of complex assembly). In these models, the type I complex shows the structural basis for γ c ability to recognize six different γ c cytokines, whereas type II complexes show an unusual top-mounted Ig-like domain on IL-13Rα1 for a novel mode of cytokine engagement, perhaps responsible for the reversal in the IL-4 versus IL-13 ternary complex assembly (21) . IL-4Rα is depicted in blue for the three models; γ c and IL-13Rα1 are brown for type I and type II complexes, respectively; and IL-4 and IL-13 are fuchsia. (b) Dimerization of the type I and II receptors activates the Janus kinases, Jak1, Jak3, and Jak1, Jak2, Tyk2, respectively (25) (26) (27) . IRS2, the main member of the insulin receptor substrate family in hemopoietic cells, is also recruited to the receptor complex (23) . Phosphorylated IRS activates PI3K and the adaptor Grb2 (18) . STAT6 (28) is recruited to the receptor complex and tyrosine phosphorylated. Phosphorylated STAT6 dimerizes, migrates to the nucleus, and binds to promoters of genes (28) . Additional signals may be mediated by the recruitment of the adaptor protein Shc. (32) (33) (34) . In contrast to the PPARs, GCs interact with IL-4 in a synergistic fashion, with the combination of stimuli inducing special features. IL-4 per se induces the loss of surface expression of TGF-βRII, whereas simultaneous stimulation with relatively low concentrations of the GC dexamethasone (1 × 10 −8 M) suffices to maintain detectable TGF-βRII on the surface (35) . Pharmacological concentrations of dexamethasone lead to enhanced surface expression and prolonged TGF-β-mediated signaling. A similar mechanism is responsible for the expression and function of the membrane protein stabilin-1. The combination of GC and IL-4/IL-13 induces an increase and stabilization of the levels of its messenger and protein but, more importantly, activates two distinctive intracellular trafficking pathways for receptor-mediated endocytosis and recycling, resulting in stabilin-1 shuttling between the endosomal compartment and the trans-Golgi network. The major role of stabilin-1 seems to be that of a homeostatic scavenger receptor for endogenous signals such as acLDL (acetylated low-density lipoprotein), SI-CLP (chitinase-like protein), and SPARC (secreted protein, acidic, cysteinerich), the delivery of newly synthesized proteins from biosynthetic to secretory pathways, and perhaps mediation of leukocyte adhesion and transmigration (36) .
Other molecules also influence the expression of aaM genes in vivo. Galectin-3 is a membrane molecule that participates in a feedback loop that causes sustained PI3K activation via activation of CD98. siRNA-targeted depletion of galectin-3, murine KO models, and specific galectin-3 inhibitors block the expression of the main aaM markers, thus supporting a role as a key mechanism in IL-4/IL-13 pathways (37) . These data confirm the notion that PI3K signaling plays an important role in alternative M activation in vivo. SHIP1 (SH2-containing inositol-5-phosphatase) is a potent negative regulator of the PI3K pathway in hemopoietic cells. M s in mice with a targeted deletion of SHIP1 had increased expression of alternative activation markers, a property that appears to be dependent on TGF-β present in vivo (38) .
Ablation of the well-known cytokine IL-10 can also inhibit the upregulation of aaM markers in response to African trypanosomiasis (39) . The increase in aaM markers coincides with the appearance of IL-10, which could suggest dependence on IL-10. In this IL-10 KO experimental model, of a dozen aaM markers tested, all returned to the levels found in noninfected wild-type (WT) mice. Note that IL-21 receptor KO mice are also deficient in pulmonary aaM s following infection by Nippostrongylus brasiliensis and the filarial nematode Schistosoma mansoni (40) . Does this make IL-10, IL-21, and galectin-3 subcomponents of the IL-4 pathway, as with IFN-β for the IFN-γ and TLR4 pathways? Accurate interpretation of these results and critical analysis of the pathways will be essential to understand the contribution of IL-4/IL-13, and other signals, to alternative activation of M s in the development of a Th2 immune response, where multiple signals are produced both sequentially and in unison.
THE CELLS BEHIND MΦ ALTERNATIVE ACTIVATION
The main characteristics of IL-4 and IL-13, as well as their sources in inflammation, have long been known ( Table 1) . Several cell types produce IL-4 and IL-13, including conventional CD4 + Th2 and CD8 + T cells (41, 42) , NKT cells (43) , basophils (44) , mast cells (44, 45) , and eosinophils (46) , which suggests that alternative activation can be of both innate and acquired origin. Their production is allele restricted in Th2 cells, whereas in innate immune cells the expression is biallelic (47); major epigenetic alterations involving chromatin reorganization and transcription factor activation control their expression. Among other mechanisms, synergistic activation of the 3 IL-4 and CNS1 (conserved noncoding sequence-1) enhancers during Th2 priming leads to high levels of IL-4 and IL-13 transcriptional permissivity, rather than to transcription itself, which correlates with an enhanced capacity of Th2 cells to express either, or both, cytokines (48) . Thus, the studies presented here, although focused on IL-4, possibly also reflect the production of its immediate neighbor, IL-13. This supposition is strengthened by the fact that many of the effects observed in these models, such as fibrosis, mucus secretion, and parasite expulsion, depend on IL-13 rather than IL-4 (49) .
Although the origin of the cytokines is broadly known, the precise contribution of each cell type to the bulk of cytokine produced in acute and chronic inflammatory settings remains elusive. Helminthiasis and asthma are the most common Th2 disease models used to study IL-4 and IL-13 production and consequent M alternative activation. The involvement of the Th2 arm of the immune system in tissue repair is less clear, although Th2 cytokines, especially IL-13, have been associated with fibrosis, essential for parasite containment, but also for wound healing. Consequently, relatively few studies have addressed this question. Useful transgenic mice have been developed for components of the IL-4/IL-13 pathways, although only recently has IL-4 expression been associated with green fluorescent protein (GFP) expression: GFP + IL-4 + (50) and the 4get mouse (51) ( −/− mice, which lack B or T cells, showed no significant differences from WT animals in the early effector response, supporting its association with cells of innate origin (52) .
N. brasiliensis, another commonly studied nematode, causes infections typically associated with intestinal pathology, although the host can develop, in addition, a profound pulmonary mucus response (51, 53, 54) . Infection of 4get mice with this pathogen showed that eosinophils were the most prevalent cell type, increasing up to 1000 times, with Th2 cells and basophils comprising three and ten times lower cell numbers, respectively (55) . After ten days of infection, 40% of the total CD4 + T cells in the lung spontaneously expressed GFP. Importantly, CD4 + T cells in spleen and draining mesenteric lymph nodes were 15%, with a significant 5% CD4
+ cell accumulation in nondraining peripheral lymph nodes (51) . In response to the nematode Heligmosomoides polygyrus, the cell infiltrate was similar to that induced by N. brasiliensis. In this study, the frequency of CD4 + /GFP + Th2 cells increased in peripheral blood lymphocytes and in all lymphoid organs analyzed, including the draining mesenteric lymph nodes, spleen, and Peyer's patches, but also in some tertiary sites such as the lung (56 can be produced outside the primary inflammatory locus, thus possibly affecting the activation of widely distributed M s in secondary and even tertiary organs. While in 4get mice the predominant myeloid cell making IL-4 is the eosinophil, the same pathogen in GFP + IL-4 + showed that basophils were far and away the most numerous IL-4-producing cells (57) . The nature of these differences remains to be defined. GFP + IL-4 + mice were also used by Chen and colleagues (47) In the Th2 response induced by alum adjuvants, the IL-4 reporter signal was restricted to CD4 + T cells in draining lymph nodes throughout the duration of the experiments, without apparent involvement of innate immune sources (58) (see Table 3 ).
Kang and colleagues (59) demonstrated that in addition to hemopoietic cells, adipocytes are a source of Th2 cytokines, especially IL-13. In 3T3-L1 adipocyte cell lines, expression of IL-13 is dramatically induced upon differentiation from preadipocytes to adipocytes, with similar results in differentiated human adipocytes. IL-4 was also induced in differentiated adipocyte cell lines but was undetectable in human adipocytes under the same conditions. ELISAs quantifying IL-13 and IL-4 concentrations showed that IL-13 was tenfold and fourfold higher than IL-4 in media from 3T3-L1 adipocytes and primary adipocytes, respectively. The IL-13 produced by adipocytes is relevant to the homeostasis of adipose tissue and regulation of diseases, such as control of insulin resistance associated with the metabolic syndrome.
EFFECTOR FUNCTIONS OF ALTERNATIVELY ACTIVATED MΦS IN THE TH2 IMMUNE RESPONSE
The connection of classical activation with the well-understood Th1 response, first demonstrated at cellular levels and then in molecular detail, soon made it broadly accepted. Alternative activation has remained ill defined for many years, perhaps influenced by the fact that in contrast to classical activation, it started as an in vitro paradigm, and for years little was done to understand the effector function of M s in vivo. The goal of the Th2 response is the elimination and control of infection by extracellular pathogens such as helminths. The size of these pathogens impedes their phagocytosis, and thus M s and dendritic cells (DCs) developed other functions to sample, present their antigens, and perhaps eliminate them. It has been hypothesized that Th2 immune responses control helminth infection by challenging and directly causing damage to the parasites, which in turn deviate their priorities from reproduction to defense; intense mucus production and increased muscle motility promote physical expulsion of the invading organisms. How M s contribute to this response should Similarly to IFN-γ, IL-4 and IL-13 modify the function of M s at various levels, with some mechanisms strictly dependent on direct signaling and others also requiring de novo gene expression. In contrast to IFN-γ, which increases phagocytosis via selected receptors, IL-4, through direct PI3K activation, increases the capacity for fluid-phase pinocytosis, MRC1-dependent endocytosis, as well as MRC1-independent micro-and macropinocytosis (60, 61) . At the cellular level, IL-4 increases tubular vesicle formation at the pericentriolar region, associated with trafficking of recycling and early endosomes, concurrent with decreased particle sorting to lysosomes (60) . The combination of IL-4 with PGE2 increases the size of early endosomes, endoplasmic reticulum, and Golgi compartments, in parallel with MRC1-mediated and fluid-phase endocytosis (62) . IL-4 in combination with GM-CSF also affects lamellipodia formation in M s via Rac-1 activation, without consequences for the uptake of latex beads (63) . In contrast, another study shows that phagocytosis of latex beads is decreased in aaM (64) . The endosomal stimulation by IL-4 may support increased antigen uptake and presentation of soluble extracellular antigens, providing a mechanism for cytokinedependent enhancement of antigen uptake in bystander M s (60) . Increased sampling of the extracellular environment by M s and DCs is crucial for MHC class II presentation of pathogens, such as helminths, that cannot enter the phagocytic pathway. Autophagy, a process that resembles phagocytosis, is a catabolic mechanism involving the degradation of a cell's own components through its lysosomal machinery. Autophagy is important for innate immunity against intracellular pathogens such as Mycobacterium tuberculosis (65) . IL-4 inhibits autophagosome formation induced by starvation and reduces the number of IFN-γ-induced autophagic vacuoles (65) . Importantly, during mycobacterial infection, alternative activation of M s does not affect phagosome maturation, but inhibits autophagy-dependent maturation and killing of mycobacteria (66) . IL-4 may spare investing energy and resources in presentation of intracellular antigens in the antihelminthic response.
IL-4 and MΦ Fusion
IL-4 and IL-13 induce M fusion with formation of multinucleated giant cells in vitro (67) . This phenomenon can be observed during granulomatous responses induced by infection with several pathogens, e.g., S. mansoni and M. tuberculosis, and is also present during the foreign body reaction. M fusion and therefore multinucleation is also the basis of the formation of osteoclasts induced by RANKL and M-CSF (49, 50) . While osteoclasts have the capacity to degrade bone, we can only speculate that IL-4-and IL-13-induced polykaryons may acquire the ability to degrade large components that cannot otherwise be internalized by individual M s. This may be important for the degradation of large extracellular parasites and foreign materials such as implants. However, M fusion could have other functional consequences such as complementation of the properties of individual M s and enhanced/decreased antigen presentation, pathogen killing, or secretory activity.
The potential benefits or costs of fusion and the contribution of IL-4/IL-13 to M fusion in vivo remain largely unknown. Given that alternative activation induced by IL-4 and IL-13 does not induce giant cell formation in all situations, we can postulate that extra signaling pathways are required, which could originate from the recognition by M s of foreign materials such as schistosomal eggs, and mycobacteria, among others (68, 69) . In line with this hypothesis, adhesion to a permissive substratum but also the inflammatory status of the M s are 
IL-4 and IL-13 Gene Signatures in MΦs: A Species Matter
Although the signaling cascade induced by IL-4/IL-13 modulates key effector functions of M s such as endocytosis, those effects cannot be compared with the repercussions of de novo IL-4-associated gene programs (16, (71) (72) (73) (74) . These gene expression programs determine to a great extent the altered functions acquired by aaM s. In the past decade, information about IL-4 effects on M gene expression has grown exponentially owing to the sequencing of the complete human and murine genomes and the establishment of tools to assess gene expression at full genomic level. Efforts by several investigators have yielded comprehensive gene profiles of IL-4-and IL-13-stimulated M s, providing novel candidate markers for alternative activation while clarifying differences among species and between these cytokines and other inflammatory factors (16, (71) (72) (73) (74) . Importantly, although the general functions and behavior of murine and human aaM s are expected to be highly conserved, our own unpublished data suggest that the genes modulated by IL-4 in each species are different to some extent. Quantitatively, the changes in the M transcriptome induced by IL-4 and IL-13 alone are more restricted than the gene expression programs induced by LPS or LPS in combination with IFN-γ, but similar in magnitude to the effect of IL-10, IFN-γ alone, oxidized LDL, and GCs (16) . Qualitatively, although distinctive, the nature of IL-4 and IL-13 profiles at times overlaps with those of other cytokines, e.g., IL-10 and GC (16) . Before discussing the main gene signatures associated with IL-4 and IL-13, note that most of our current knowledge of aaM gene transcription originates from studies carried out in murine models, whereas human studies are scanty ( Table 2) . Thus, it will be crucial to keep updating this subject as further evidence is produced.
Among the group of genes extensively studied in mouse M s, arginase 1 (ARG1) is a prototypic alternative activation marker. The expression of ARG1 induces a shift of arginine metabolism from the IFN-γ-induced production of NO via iNOS toward production of ornithine and polyamines, which are important for wound healing (75) . Similar to IFN-γ-driven tryptophan depletion, arginine depletion in IL-4-treated M s can also lead to inhibition of T cell proliferation (76) . Although homologs exist in humans, both ARG1 and iNOS induction are confined mainly to murine M s (77, 78) . Other murine restricted markers lack homologs in humans including YM1 and YM2 (CHI3l3 and CHI3l4), members of the chitinase family (79, 80) , and FIZZ1 (found in inflammatory zone 1, RETNLA) (80, 81) . YM1 and YM2 are members of the glycosyl hydrolase 18 family, which includes other hydrolases such as the acidic mammalian chitinase (AMCase), an enzyme able to hydrolyze chitin, a polymer of N-acetylglucosamine. Chitin is not expressed in mammalian systems but is abundant in the structural coat of fungi, the exoskeleton of many arthropods, and parasitic nematodes. Both YM1 and YM2 lack chitinase activity, and although it has been hypothesized that they function as lectin binding proteins or cytokines, no clear evidence exists in support of this function.
Human M s also have restricted expression of alternative activation markers. An interesting gene signature present in human but not in mouse aaM s is that of nucleotide G protein-coupled receptors (GPCRs). IL-4 activation is characterized by the expression of a restricted group of GPCRs, five of which constitute nucleotide and sugar nucleotide (82, 83) . One postulate of the concept of M alternative activation is the acquisition of an entirely different phagocytic receptor repertoire. Of all the murine and human alternative activationassociated receptors, MRC1 has been most comprehensively studied. It is detected in most tissue M s but also in hepatic and lymphatic endothelia, as well as in glomerular mesangial cells. MRC1 was identified because of its ability to recognize endogenous glycoproteins, such as lysosomal hydrolases, but MRC1 also mediates the uptake of mannosylated antigens, cell-cell contact through its interaction with l-selectin, binding and uptake of agalactosyl IgG, and importantly, pathogen recognition. MRC1 interacts with a wide range of microorganisms including the fungus Candida albicans and several species of mycobacteria and Leishmania (84) . Current data suggest a role for MRC1 in cell signaling, perhaps associated mainly with inhibition of IL-12 production in response to endotoxin and production of the antiinflammatory cytokines IL-10 and IL-1Ra (IL-1β receptor antagonist) and of the nonsignaling IL-1RII (IL-1β decoy receptor) (85) .
In addition to upregulating MRC1 expression, IL-4 and IL-13 regulate a broad set of phagocytic receptors. IL-4 and IL-13 upregulate M scavenger receptor 1 (MSR1) with clear roles in pathogen recognition and lipoprotein clearance, the C-type lectin-like receptor Dectin-1, with specificity for β-1,3-and β-1,6-linked glucans, found in fungi and some bacteria, and a known role in TLR2 signaling (85) . DC-SIGN, also an alternative activation marker, was first identified through its binding to ICAM-2 and 3, facilitating antigen presentation and costimulation (85) . This receptor plays a role in innate recognition of a plethora of pathogens including M. tuberculosis, C. albicans, Helicobacter pylori, Leishmania mexicana, and S. mansoni. Less well described markers of human M alternative activation are DCIR and DCL-1 (71, (86) (87) (88) (89) . IL-4 and IL-13 induce the expression of MGL1/2 (CLEC10A in humans) and CD23 in both species. Functionally, murine MGL has been documented to be involved in the recognition and endocytosis of galactosylated glycoproteins (90, 91) , where MGL1 binds preferentially to Lewis X moieties and MGL2 shows specificity for α-GalNAc or β-GalNAc residues (92). MGL1 has been implicated in M homing, granuloma maintenance (93) (94) (95) (96) , and suppression of proinflammatory cytokines (97) .
The other postulate of the alternative activation concept is the acquisition by M s of a secretory repertoire entirely different from that of classical activation. It is well accepted that IL-4 and IL-13 mediate repression of proinflammatory cytokines and induction of an antiinflammatory milieu (16) . In addition to antagonizing the secretion of IL-12, IL-1β, TNF, and IL-8 induced by classical activation and other proinflammatory factors (11, 98) , IL-4 and IL-13 have other means to downregulate a pro-Th1 response. In humans, aaM s express less IL-1β but also more IL-1RII and IL-1Ra (99) . Downregulation of caspase-1, the enzyme responsible for the activation of IL-1β, contributes to downregulation of its secretion (72); importantly, this system also processes IL-18. However, this property may change in certain conditions, in which IL-4 may increase the production of inflammatory cytokines (100). Human and murine aaM s secrete a number of fibrogenic factors such as fibronectin 1 (FN1) and matrix associated protein βIG-H3 (74, 101) , and the coagulation factor XIII (F13A1) (102), which bears transglutaminase activity. They also produce insulin-like growth factor 1 (IGF1) (71, 103) and platelet-derived growth factor C, which provide signals for tissue proliferation and repair (101) .
One function of IFN-γ is amplification of the inflammatory infiltrate, through production of selected chemokines. Importantly, one Human and murine macrophage alternative activation markers. M alternative activation is associated with changes in M function and distinctive gene signatures. Although the alternative activation markers for human (a) and murine (b) M s have long been considered analogous, there are differences between species. IL-4 and IL-13 induce genes conserved in both species such as MHC class II (MHCII) and MRC1, as well as divergent ones such as ARG1, YM1 in mouse, and GPR105 in humans. Despite gene evolution, there is conservation of function, i.e., different chemokines attract similar cellular infiltrates in both species. Hitherto, fusogenic molecules have been identified only in mouse. The divergences between species and their functional repercussion require further investigation. 
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Necessary Alternative Activation
Helminths are parasitic worms that represent the most common infectious agent in developing countries, affecting close to three billion people. Helminths comprise two phyla: nematodes and platyhelminths, further divided into cestodes and trematodes. Protection against both phyla depends on IL-4 and IL-13. Several murine models have been used to study the immune response to gastrointestinal nematodes and the contribution and phenotype of the participating M s ( Table 4) . Experimental infection by N. brasiliensis is performed subcutaneously, and as the parasites mature, they migrate and enter the lungs where they induce strong, polarized Th2 responses in situ and in lung-associated lymph nodes (51, 53, 54) . Lung pathology is associated with a strong induction of alternative activation in alveolar M s, as shown by elevated expression of YM1 and FIZZ1 (40, 54) . In this model, aaM s do not participate in worm expulsion following primary infection (110, 111) , while examination of lung pathology in response to migrating larvae from N. brasiliensis and also in the memory response to another nematode, H. polygyrus, demonstrates a clear contribution of aaM s (111) . Chronic induction of aaM s drives lung fibrosis, consistent with the wound-healing functions of aaM s induced by the filarial nematodes B. malayi, and also drives inhibition of inappropriate CD4 + proliferative responses in the later stages of Litomosoides sigmodontis (112, 113) . Though mice are usually able to resolve primary gastrointestinal nematode infections, reinfection with H. polygyrus has shown aaM s to be critical for induction of effective memory responses to secondary infection (111) . This finding is in agreement with the requirement of antigenpresenting cells (APCs), and specifically of (110) . In this setting, M s express the alternative activation markers ARG1, YM1, and FIZZ1. It has been proposed that aaM s mediate repair of tissue damage and dampen excessive inflammation resulting from traversal of parasite eggs across the intestine, and are therefore important for host survival from acute schistosomiasis (110) . Similar mechanisms may operate in humans, where infection by S. mansoni correlates with production of TNF-α, IL-4, and IL-5. A positive correlation is found between cytokine secretion and severity of the disease, measured as periportal fibrosis versus intestinal pathology (116) . Infection of mice with the cestode Taenia crassiceps induces a mixed Th1/Th2 immune response (117) , and unlike the case of infection with the other helminths discussed, caM s play a major role in clearing T. crassiceps infection (118) . However, when the infection progresses to a chronic stage, Th2 cytokine dominance results in aaM recruitment that controls excessive inflammatory responses and increased CD4
+ apoptosis (119) (120) (121) (122) .
Unwanted Alternative Activation
Asthma is a chronic inflammatory disease of the airways characterized by IgE production, goblet cell metaplasia, airway smooth muscle proliferation and hyperplasia, and airway hyperresponsiveness, together with enhanced expression of selected cytokines and chemokines. There is overwhelming evidence that chronic allergic inflammatory processes depend on expression of the Th2 cytokines IL-4, IL-5, IL-9, and IL-13 (123, 124) , highly expressed in airway tissues from asthmatic patients. In murine models of asthma, alveolar M s express the alternative activation markers Ym1, FIZZ1, and ARG1 (47, 125) . There are other congenital noninfectious autoimmune and idiopathic inflammatory diseases, with increased levels of IL-4 and IL-13, generally accompanied by eosinophilia, impaired cellular responses, and increases in one or more B cell activities, such as hypergammaglobulinemia, autoantibody production, or particularly increased IgE production. Examples are Ommen's syndrome, the hypereosinophilic syndrome (HES), Kimura's disease, and Job's and Wells' syndromes. Unfortunately, as for most human-related pathologies, no studies address their association with alternative activation of M s. Viruses benefit from a Th2 environment, and a remarkable example is that of dengue virus, a mosquito-borne flavivirus that can cause hemorrhagic fever in humans. This virus is transmitted to humans by the mosquito Aedes aegypti; its salivary factors induce a shift in cytokine expression with downregulation of the type I and type II IFN response and enhanced expression of Th2 cytokines (126) . These Th2 cytokines not only dampen the Th1 response required for viral elimination but also induce MRC1, which binds all four serotypes of dengue virus and can be exploited by the virus to infect M s (127) . Murine gamma herpes virus 68 (MHV-68), from the same family of the human Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus, induces latent infection in lymphoid tissue in IFN-γR KO. In these mice, infection results in transient fibrosis in multiple organs, with the spleen severely affected (128) . Fibrosis is preceded by infiltration of germinal centers by different subsets of splenic M s. These M s express high levels of ARG1 and murine M In fungal infections, such as the welldescribed Candidiasis, Th1 responses correlate with host reactivity and asymptomatic or mild forms of the infection, in contrast to the correlation between Th2 cell responses, severe disease, and the establishment of fungal allergies (129) . A novel example is Cryptococcus neoformansinduced bronchopulmonary disease, in which IL-4-and IL-13-mediated immune mechanisms exacerbate disease. Intranasal infection with C. neoformans of IL-4Rα1, IL-4, and IL-13 KO animals and of IL-13 transgenic and WT mice showed that lack of the receptor or of the cytokine correlates with significantly milder pathology, whereas overexpression was correlated with higher fungal brain burden and consequent cerebral lesions. Furthermore, IL-13 + transgenic mice harbored large pseudocystic lesions in the CNS parenchyma, bordered by voluminous foamy aaM s containing intracellular cryptococci, without significant microglial activation. In WT mice, aaM s tightly bordered pseudocystic lesions, and these mice, in addition, showed microglial cell activation. As expected in resistant IL-4 −/− , IL-13 −/− , and IL-4Rα −/− mice, no alternative activation markers were discernible. Microglial cells of all mouse genotypes neither internalized cryptococci nor expressed markers of alternative activation, although they displayed similar IL-4Rα expression as M s. These data provide the first evidence of the development of aaM in a CNS infectious disease model and point to distinct roles of M s versus microglia in the CNS immune response against C. neoformans (130) .
Protozoans constitute a group of pathogens that appear to require Th1 responses to be killed. In murine models, for example, successful resolution of cutaneous infection with the protozoan L. major depends on the host launching an effective Th1 response, enabling caM s to phagocytose and kill the parasites (131) (132) (133) . In the Th2-biased BALB/c, mice develop fatal progressive disease within 3 months of infection. During this time period, deletion of either IL-4 or its receptor made it possible to contain infection, with reduced footpad swelling and parasite load, moderate histopathology, and reduced Th1 response (134) . However, these mutant mice were not able to heal as completely as the infected Th1-biased C57BL/6 mice, indicating that additional factors are necessary for subsequent healing and elimination of the pathogen. In longer infection time points such as 6 months, IL-4Rα −/− mice developed progressive disease with massive footpad swelling, ulcerative and necrotic lesions with subsequent destruction of connective tissue and bones, as well as dissemination into organs and consequent mortality. In striking contrast, IL-4 −/− mice maintained control of infection on a moderate level but were unable to clear the pathogen, suggesting that IL-13 and not IL-4 plays a protective role during chronic leishmaniasis (135) .
In general, alternative activation induced by Th2 responses against helminth infections, asthma, and other pathologies can modulate the immune response in a "bystander" fashion, perhaps explaining the high rate of concomitant infections in developing countries, where secondary infections of protozoan may be facilitated. Epidemiologic studies show common coinfections of helminth and protozoa in humans, including Schistosoma/ leishmaniasis, Litomosoides/leishmaniasis, Taenia/leishmaniasis, Taenia/trypanosomiasis, filaria/malaria, or helminth/tuberculosis (136).
Non-Th2-Related Alternatively Activated MΦs: Do They Exist?
Other forms of M phenotypes have been categorized as aaM . These include M s present during tissue repair and those of several chronic pathologies such as cancer and atherosclerosis. aaM s are expected to have strong profibrotic Further data are required to strengthen these observations. TAMs have also been described as aaM (137, 138) . No consistent evidence connects IL-4 or IL-13 with tumor progression or the tumor microenvironment, indicating that other cytokines and mechanisms may influence the phenotype of TAMs. In murine and human TAMs, increased levels of p50, the inhibitory subunit of NF-κB, reduce the production of MyD88-dependent IL-12p70 and TNF (139, 140) . Importantly, MyD88-independent IRF-3, which induces IL-10 and chemokines, is preserved, leading to dampening of the inflammation. The tumor microenvironment is essential for maintenance of this phenotype, which is lost in culture after 24 h. In accordance with the defects in the NF-κB pathway, TAMs express high levels of IL-10, Dectin-1, MGL1, TGF-β, and SRA; high levels of CXCL10, CXCL9, and other IFN-responsive genes; and low levels of IL-12, TNF-α, and NOS2 (139, 140) . Thus, TAMs represent a unique M population, without a clear correlation with IL-4 or IL-13 stimulation. TAMs are characterized by expression of genes in common with aaM s, probably the same genes that IL-4 modulates to control inflammation, but also coexpress IFN-γ-inducible chemokines and other genes (139) .
Atherosclerotic plaques are characterized by a prominent M infiltrate. These M s display a foamy appearance, owing to accumulation of intracellular lipid droplets. The role of IL-4 in atherosclerosis has been investigated in several mouse models; however, the correlation between these cytokines and the disease is not clear. While exogenous IL-4 has protective or deleterious effects, depending on the mouse model used, most KO models for IL-4 components tend to develop milder disease (141, 142) . The IL-4 −/− /ApoE −/− -mice have a significant temporary reduction in the aortic root plaque area compared with ApoE −/− -mice. Immune cell-specific deficiency of IL-4 in hypercholesterolemic, cholate-fed female LDLR −/− mice provokes a reduction in atherosclerosis in the arch/thoracic regions of the aorta, but not in the aortic root. Accelerated fatty streak formation induced by heat shock protein 65 or M. tuberculosis is reduced in IL-4 −/− mice compared with lesions in WT mice. Taken together, the majority of findings would suggest a proatherogenic role for endogenous IL-4; this effect appears to be greatly influenced by the vascular site and the disease stage. Importantly, although IL-4 may play a role in the disease itself, in vitro studies of human and mouse foam cell M models do not show a significant overlap between the gene expression profile of these cells and aaM s.
MΦ ACTIVATION REVISITED
M s appear early in development, occupying strategic positions in different organs, and they persist throughout adult life. As part of their innate immune role, they act as sentinels in tissues, encountering pathogens and orchestrating the attraction and development of more complex acquired responses. M s are not the only effector cells of the immune system; DCs, neutrophils, basophils, eosinophils, and T and B cells all participate in the defense against pathogens. As such, the view of the immune response as mere interaction between the APC and the T cell is somewhat limited. DCs and M s recognize pathogen or injury signals and then provide signals to initiate the inflammatory response. This initial interaction between pathogen-conserved moieties and the M induces a primed state in M s. The receptors for this initial activation include mainly PRRs for PAMPs, such as TLRs, NALPs, and other With the recruitment of IFN-γ-or IL-4 secreting cells of the innate system, conditions are created for the further development of either a Th1 or a Th2 milieu. The appearance in the inflammatory focus of either of these cytokines induces either classical or alternative activation, first in an innate manner (given the origin of the cytokine) and subsequently in an acquired process (Figure 3) . For T cells, a twosignal activation model is currently accepted, in which the first signal originates from ligation of the T cell receptor (TCR) by APC MHCpeptide and the second signal, in the form of a cytokine, is provided by the APC, M s, or DCs (Figure 3) . Thus, T cell and M activation seems to occur in an interdependent two-step fashion. This staged activation may also apply to DCs. Significantly, in addition to IFN-γ or IL-4/IL-13 signal recognition complexes, there is a group of M signaling receptors whose ligation also leads to M activation. These receptors respond to a wide variety of stimuli of both innate and acquired origin, including the cytokines IL-10, IL-1, IL-6, TNF, IL-17, and Table 6) . Confusion arises from the fact that the term "activation" may be correctly used at both an immune response level, as we use it throughout this manuscript, and from a wider Mcentered point of view. In the first application, activation is seen as the acquisition of resistance against specific pathogens, in response to clearly discernible arms of acquired immunity, Th1 and Th2 responses (Figure 3) , whereas in the second case, it is considered as any stimulus that moves M s from their resting condition ( Table 5) . At the level of the immune response are Th1, Th2, Th17, and a set of immune-suppressive T cells, whose main characteristic is their mutual exclusion (143) . These immune response specificity-determining cytokines have evolved to deal with either activation against specific pathogens or deactivation of the immune response and resolution. As such, it is natural to suppose that they induce four main effector phenotypes in M s. While classical and alternative activation of M s and their co-T cell Th1 and Th2 partners are in part understood, the role of IL-17 and other polarized T cell products in M s remains largely unknown. The other stimuli are also important because they play a definitive role in modification of the M phenotype in the course of an immune response and may be abundant in specific pathologies; however, they do not represent an immunologic equivalent to the Th cytokines.
In 1999, Goerdt and colleagues (144) proposed a classification of activation phenotypes based on grouping all activators other than IFN-γ and LPS/microorganisms into a common alternative activation group. This classification overlooks important immunological differences in the response to modulators such as IL-4, IL-13, IL-10, glucocorticoids (GC) and TGF. For this reason, in 2002 an extended classification was proposed in which M1 polarization included the classical activation, whereas M2 polarization was subdivided into M2a, corresponding to aaM ; M2b, corresponding to type II-activated M s; and M2c, which includes heterogeneous M deactivation stimuli (145) . The classification took into account the production of IL-10 or IL-12, which by themselves are not enough to categorize the phenotypes. Nevertheless, the classification M1/M2 is useful because it avoids using the terms alternative and classical, which can create confusion. In addition, M1 and M2 are mnemonic and provide a clear link to the T cell response. We suggest keeping classical/M1 or alternative/M2 as synonyms for those categories, and use the ligand/ligands to identify the other phenotypes until a consensus is reached in the community. We strongly suggest avoiding the grouping of stimuli other than IL-4 and IL-13 under the M2/alternative group.
CONCLUDING REMARKS
We have reviewed recent information regarding the effects of IL-4 and IL-13 and have summarized the main evidence while analyzing the robustness of alternative activation of M s as an immunological paradigm. IL-4 and IL-13 can be actively produced by both innate and acquired immune system cells. Their in vivo production may not be restricted to the primary inflammatory locus. Production of IL-4 by innate cells allows induction of aaM s prior to the secondary immune response. The innate production of IL-4 is important for tissue repair and complements IL-4 production by acquired immune system cells in the control of specific pathogens.
IL-4 and IL-13 pathways have convergent and divergent features, accounting for differences and similarities in the phenotype induced in M s. Even the identical type II receptor heterodimer, coupled to the same intracellular signaling molecules, responds to IL-4 and IL-13 with different signaling potencies and kinetics. It is the balance between activation of IL-4 type I and type II receptors and IL-13Rα2 signaling www.annualreviews.org • Alternative Activation of Macrophagescascades and their relation with other autocrine, paracrine, and cell-cell contact pathways that determines the phenotype of aaM s.
IL-4 and IL-13 modify the function of M s at various levels, with some mechanisms strictly dependent on direct signaling and others also requiring de novo gene expression. Gene expression studies have demonstrated that the effect of IL-4 or IL-13 in M s is not restricted to isolated genes, but instead involves specific and distinguishable gene signatures. In all, the number of well-characterized specific alternative activation markers does not exceed a dozen. Although the general functions and behavior of murine and human aaM s are thought to be preserved, the genes required for such functions are to some extent different. IL-4 and IL-13 induce varied effects on human and murine M s.
The functional significance of genes induced by IL-4 and IL-13 is difficult to interpret owing to the restricted information available. However, these cells clearly play a key role in the attraction of cells to inflammatory foci, suppression of Th1 responses, sampling of the microenvironment by endocytosis, and orchestration of tissue repair. Their role in pathogen killing is less clear. The combination of cytoskeletal changes induced by IL-4 and the receptor repertoire of IL-4-treated M s makes possible an altered phagocytic and secretory capacity in response to viruses, bacteria, fungi, and helminths, not always with positive consequences for the M or host.
FUTURE ISSUES
The paradigm of alternative activation of M s now emerges with greater clarity. The development of novel transgenic mice, highthroughput gene expression and proteindetection techniques, infection models, and other advances have improved our understanding of the Th2 response, the cells that participate in it, and their cross talk, as well as the effector functions of aaM s.
Human and murine M s, although having functions in common, clearly express different genes in response to both IL-4 and IL-13. Given the feasibility and versatility of mouse models, most of our knowledge derives from them and not from human studies. Considering the differences between species, we must investigate human alternative M activation in more depth, both in vitro and in vivo. Validation of specific markers, gene silencing, and transfection of human primary M s may become powerful tools for this purpose.
Initiation of the Th1 response, the link between microbial PAMPs and production of proinflammatory cytokines, and the killing capacity of caM s are more or less well understood. However, little is known about the extracellular parasite PAMPs, their recognition by APCs, and the link to initiation of the Th2 response and cytokine production. Similarly, many of the genes and functions of aaM s, especially their antiparasitic properties, are still unidentified. Further studies are required to understand host defense against such parasites.
Accumulating evidence suggests that M s play major roles in pathology, and several of their products and effector functions make them ideal therapeutic targets. We have reviewed a number of diseases that result from dysregulation of the Th2 response. Similarly, many diseases arise from dysregulation of the Th1 response. To date, the therapeutic interventions that target M s rather than their products, e.g., TNF, are limited (146) , although a number of M specific drugs are emerging. Cell therapy is also a future possibility, and studies are beginning to assess the beneficial effects of ex vivo M activation and transfusion, with encouraging results (147, 148) .
SUMMARY POINTS
1. The finding of a M classical activation, induced by IFN-γ in response to infection with unrelated intracellular pathogens, represents one of the turning points in M biology 4. The pathways of IL-4 and IL-13 have convergent and divergent features, which account for differences and similarities in the phenotype induced in M s. It is the balance between activation of IL-4 type I and type II receptors and IL-13Rα2 signaling cascades in relation to other autocrine, paracrine, and cell-cell contact-induced pathways that finally determines the phenotype of aaM s.
5. IL-4 and IL-13 can be produced by both innate and acquired immune system cells. Their in vivo production may not be restricted to the primary inflammatory locus.
6. Innate production of IL-4 is likely to be important for tissue repair and to complement IL-4 production by acquired immune cells in the control of specific pathogens.
7.
Gene expression studies have demonstrated that the effect of IL-4 or IL-13 in M s is not restricted to isolated genes, but instead involves specific and distinguishable gene signatures. These gene signatures depend on the genetic background, maturation, and activation state of cells.
8. Although the general functions and behavior of murine and human aaM s are thought to be preserved, the genes required for such functions are to some extent different.
9. Phagocytic receptors expressed by aaM s differ from those expressed by caM s. Although not fully demonstrated, a common dual feature of these receptors seems to be pathogen and self recognition, leading to increased ligand endocytosis, but also interaction with T cells and negative immune modulation.
10
. aaM s play a key role in the attraction of other cells to inflammatory foci, suppression of Th1 responses, sampling by endocytosis of the microenvironment, and orchestration of tissue repair.
11. There is an unaccounted degree of divergence between species, still to be determined.
12. Confirmation of aaM markers in studies regarding Th2 responses has become a necessary readout to link cytokine production to the development of immune effector functions.
13. Presence of alternatively activated macrophages has been confirmed in several helminthic and allergic disease models.
